Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2015, Article ID 872431, 6 pages
http://dx.doi.org/10.1155/2015/872431
Review Article

Mystery of Hepatitis E Virus: Recent Advances in Its Diagnosis and Management

1Department of Internal Medicine, Oklahoma University Health Sciences Center, Williams Pavilion 1130, P.O. Box 26901, Oklahoma City, OK 73104, USA
2Dow Medical College, Mission Road, Karachi 74200, Pakistan
3Section of Digestive Diseases and Nutrition, Oklahoma University Health Sciences Center, Williams Pavilion 1345, 920 SL Young Boulevard, Oklahoma City, OK 73104, USA

Received 28 September 2014; Accepted 27 December 2014

Academic Editor: Maria Buti

Copyright © 2015 Aftab Ahmed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Fujiwara, Y. Yokokawa, K. Morino, K. Hayasaka, M. Kawabata, and T. Shimizu, “Chronic hepatitis E: a review of the literature,” Journal of Viral Hepatitis, vol. 21, no. 2, pp. 78–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Féray, J.-M. Pawlotsky, A.-M. Roque-Afonso, D. Samuel, and D. Dhumeaux, “Should we screen blood products for hepatitis e virus RNA?” The Lancet, vol. 383, no. 9913, p. 218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Kamar, H. R. Dalton, F. Abravanel, and J. Izopet, “Hepatitis E virus infection,” Clinical Microbiology Reviews, vol. 27, no. 1, pp. 116–138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Arends, V. Ghisetti, W. Irving et al., “Hepatitis E: an emerging infection in high income countries,” Journal of Clinical Virology, vol. 59, no. 2, pp. 81–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Kamar, R. Bendall, F. Legrand-Abravanel et al., “Hepatitis E,” The Lancet, vol. 379, pp. 2477–2488, 2012. View at Google Scholar
  6. S. Mirazo, N. Ramos, V. Mainardi, S. Gerona, and J. Arbiza, “Transmission, diagnosis, and management of hepatitis E: an update,” Journal of Hepatic Medicine: Evidence and Research, vol. 6, pp. 45–59, 2014. View at Publisher · View at Google Scholar
  7. M. T. Pérez-Gracia, B. Suay, and M. L. Mateos-Lindemann, “Hepatitis E: an emerging disease,” Infection, Genetics and Evolution, vol. 22, pp. 40–59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Pischke and H. Wedemeyer, “Hepatitis E virus infection: multiple faces of an underestimated problem,” Journal of Hepatology, vol. 58, no. 5, pp. 1045–1046, 2013. View at Publisher · View at Google Scholar
  9. J.-M. Echevarría, “Light and darkness: prevalence of hepatitis E virus infection among the general population,” Scientifica, vol. 2014, Article ID 481016, 14 pages, 2014. View at Publisher · View at Google Scholar
  10. N. Kamar, R. Bendall, F. Legrand-Abravanel et al., “Hepatitis E,” The Lancet, vol. 379, no. 9835, pp. 2477–2488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. R. Dalton, J. G. Hunter, and R. Bendall, “Autochthonous hepatitis e in developed countries and HEV/HIV coinfection,” Seminars in Liver Disease, vol. 33, no. 1, pp. 50–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Colson, P. Borentain, B. Queyriaux et al., “Pig liver sausage as a source of hepatitis e virus transmission to humans,” The Journal of Infectious Diseases, vol. 202, no. 6, pp. 825–834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. R. Dalton, “Hepatitis E: the ‘new kid on the block’ or an old friend?” Transfusion Medicine and Hemotherapy, vol. 41, no. 1, pp. 6–9, 2014. View at Publisher · View at Google Scholar
  14. P. C. Y. Woo, S. K. P. Lau, J. L. L. Teng et al., “New hepatitis E virus genotype in camels, the Middle East,” Emerging Infectious Diseases, vol. 20, no. 6, pp. 1044–1048, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Alvarado-Esquivel, L. F. Sanchez-Anguiano, and J. Hernandez-Tinoco, “Seroepidemiology of hepatitis E virus infection in general population in rural durango, Mexico,” Hepatitis Monthly, vol. 14, no. 6, Article ID e16876, 2014. View at Publisher · View at Google Scholar
  16. S. Kumar, S. Subhadra, B. Singh, and B. K. Panda, “Hepatitis E virus: the current scenario,” International Journal of Infectious Diseases, vol. 17, no. 4, pp. e228–e233, 2013. View at Publisher · View at Google Scholar
  17. T. M. Pavri, D. A. Herbst, and K. R. Reddy, “Chronic hepatitis E virus infection: challenges in diagnosis and recognition in the United States,” Journal of Clinical Gastroenterology, vol. 49, no. 1, pp. 86–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Montella, G. Reza, F. di Sora, P. Pezotti, and O. Recchia, “Association between hepatitis E virus and HIV infection in homosexual men,” The Lancet, vol. 344, no. 8934, p. 1433, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. B. A. I. Payne, M. Medhi, S. Ijaz et al., “Hepatitis E virus seroprevalence among men who have sex with men, United Kingdom,” Emerging Infectious Diseases, vol. 19, no. 2, pp. 333–335, 2013. View at Google Scholar · View at Scopus
  20. Y. Geng, H. Zhang, W. Huang et al., “Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia,” Hepatitis Monthly, vol. 14, no. 1, Article ID e15618, 2014. View at Publisher · View at Google Scholar
  21. J. H. Hoofnagle, K. E. Nelson, and R. H. Purcell, “Current concept hepatitis E,” The New England Journal of Medicine, vol. 367, pp. 1237–1244, 2012. View at Publisher · View at Google Scholar
  22. C. L. Crossan, K. J. Simpson, D. G. Craig et al., “Hepatitis E virus in patients with acute severe liver injury,” World Journal of Hepatology, vol. 6, no. 6, pp. 426–434, 2014. View at Publisher · View at Google Scholar
  23. S. Haim-Boukobza, A. Coilly, M. Sebagh et al., “Hepatitis E infection in patients with severe acute alcoholic hepatitis,” Liver International, 2014. View at Publisher · View at Google Scholar
  24. I. Al-Shukri, E. Davidson, A. Tan et al., “Rash and arthralgia caused by hepatitis E,” The Lancet, vol. 382, no. 9907, p. 1856, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Price, “An update on hepatitis B, D, and E viruses,” Topics in Antiviral Medicine, vol. 21, no. 5, pp. 157–163, 2013. View at Google Scholar · View at Scopus
  26. D. B. Smith and P. Simmonds, “Hepatitis E virus and fulminant hepatitis—a virus or host-specific pathology?” Liver International, 2014. View at Publisher · View at Google Scholar
  27. J. H. Hoofnagle, K. E. Nelson, and R. H. Purcell, “Hepatitis E,” The New England Journal of Medicine, vol. 367, no. 13, pp. 1237–1244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Aggarwal Jr., “Epidemiologic concerns and advances in knowledge on hepatitis E,” Gastroenterology & Hepatology, vol. 9, no. 3, pp. 173–175, 2013. View at Google Scholar
  29. I. Masood, A. Rafiq, and Z. Majid, “Hepatitis E presenting with thrombocytopaenia,” Tropical Doctor, vol. 44, no. 4, pp. 219–220, 2014. View at Publisher · View at Google Scholar
  30. S.-J. Huang, X.-H. Liu, J. Zhang, and M.-H. Ng, “Protective immunity against HEV,” Current Opinion in Virology, vol. 5, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Comont, D. Bonnet, N. Sigur, A. Gerdelat, F. Legrand-Abravanel, N. Kamar et al., “Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient,” La Revue de Medecine Interne, vol. 35, no. 5, pp. 333–336, 2014. View at Publisher · View at Google Scholar
  32. X. Wu, K. Liu, and H. L. Zhang, “Guillain–Barré syndrome and encephalitis/encephalopathy associated with acute severe hepatitis E infection,” Neurological Sciences, 2014. View at Publisher · View at Google Scholar
  33. A. Belbezier, A. Deroux, F. Sarrot-Reynauld, S. Larrat, and L. Bouillet, “Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman,” Emerging Infectious Diseases, vol. 20, no. 5, pp. 908–910, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Kamar, J. Selves, J.-M. Mansuy et al., “Hepatitis E virus and chronic hepatitis in organ-transplant recipients,” The New England Journal of Medicine, vol. 358, no. 8, pp. 811–817, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Zhou, R. A. de Man, R. J. de Knegt, H. J. Metselaar, M. P. Peppelenbosch, and Q. Pan, “Epidemiology and management of chronic hepatitis E infection in solid organ transplantation: a comprehensive literature review,” Reviews in Medical Virology, vol. 23, no. 5, pp. 295–304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. H. R. Dalton, R. P. Bendall, F. E. Keane, R. S. Tedder, and S. Ijaz, “Persistent carriage of hepatitis E virus in patients with HIV infection,” The New England Journal of Medicine, vol. 361, no. 10, pp. 1025–1027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Abbas and R. Afzal, “Hepatitis E: when to treat and how to treat,” Antiviral Therapy, vol. 19, no. 2, pp. 125–131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. T. Giordani, P. Fabris, E. Brunetti, S. Goblirsch, and L. Romanò, “Hepatitis E and lymphocytic leukemia in man, Italy,” Emerging Infectious Diseases, vol. 19, no. 12, pp. 2054–2056, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Wang, H. J. Metselaar, M. P. Peppelenbosch, and Q. Pan, “Chronic hepatitis E in solid-organ transplantation: the key implications of immunosuppressants,” Current Opinion in Infectious Diseases, vol. 27, no. 4, pp. 303–308, 2014. View at Publisher · View at Google Scholar
  40. N. Kamar and J. Izopet, “Does chronic hepatitis E virus infection exist in immunocompetent patients?” Hepatology, vol. 60, no. 1, p. 427, 2014. View at Publisher · View at Google Scholar
  41. J. J. van Eijk, R. G. Madden, A. A. van der Eijk et al., “Neuralgic amyotrophy and hepatitis E virus infection,” Neurology, vol. 82, no. 6, pp. 498–503, 2014. View at Publisher · View at Google Scholar
  42. A. Deroux, J. P. Brion, L. Hyerle et al., “Association between hepatitis E and neurological disorders: two case studies and literature review,” Journal of Clinical Virology, vol. 60, no. 1, pp. 60–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. de Vries, J. P. A. Samijn, R. de Man, and J. M. M. Boots, “Hepatitis E-associated encephalopathy in a renal transplant recipient,” BMJ Case Reports, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. D. J. Seo, H. Tahk, K. B. Lee et al., “Detecting hepatitis E virus with a reverse transcription polymerase chain reaction enzyme-linked immunosorbent assay,” Food and Environmental Virology, vol. 4, no. 1, pp. 14–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Vollmer, C. Knabbe, and J. Dreier, “Comparison of real-time PCR and antigen assays for detection of hepatitis e virus in blood donors,” Journal of Clinical Microbiology, vol. 52, no. 6, pp. 2150–2156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Kamar, F. Abravanel, J. Selves et al., “Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-e virus infection after organ transplantation,” Transplantation, vol. 89, no. 3, pp. 353–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Robbins, D. Lambert, F. Ehrhard et al., “Severe acute hepatitis E in an HIV infected patient: successful treatment with ribavirin,” Journal of Clinical Virology, vol. 60, no. 4, pp. 422–423, 2014. View at Publisher · View at Google Scholar
  48. N. Kamar, L. Rostaing, F. Abravanel et al., “Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection,” Gastroenterology, vol. 139, no. 5, pp. 1612–1618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Mallet, E. Nicand, P. Sultanik et al., “Brief communication: case reports of ribavirin treatment for chronic hepatitis E,” Annals of Internal Medicine, vol. 153, no. 2, pp. 85–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Wedemeyer, S. Pischke, and M. P. Manns, “Pathogenesis and treatment of hepatitis E virus infection,” Gastroenterology, vol. 142, no. 6, pp. 1388.e1–1397.e1, 2012. View at Publisher · View at Google Scholar
  51. F.-C. Zhu, J. Zhang, X.-F. Zhang et al., “Efficacy and safety of a recombinant hepatitis e vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial,” The Lancet, vol. 376, no. 9744, pp. 895–902, 2010. View at Publisher · View at Google Scholar · View at Scopus